Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
106.96
+0.47 (0.44%)
Nov 5, 2024, 1:19 PM EST - Market open
Vaxcyte Employees
Vaxcyte had 254 employees as of December 31, 2023. The number of employees increased by 96 or 60.76% compared to the previous year.
Employees
254
Change (1Y)
96
Growth (1Y)
60.76%
Revenue / Employee
n/a
Profits / Employee
-$1,957,433
Market Cap
13.23B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 254 | 96 | 60.76% |
Dec 31, 2022 | 158 | 69 | 77.53% |
Dec 31, 2021 | 89 | 31 | 53.45% |
Dec 31, 2020 | 58 | 15 | 34.88% |
Dec 31, 2019 | 43 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Universal Health Services | 96,700 |
Viatris | 38,000 |
Dr. Reddy's Laboratories | 27,048 |
Solventum | 20,098 |
Exact Sciences | 6,600 |
BioMarin Pharmaceutical | 3,401 |
Incyte | 2,524 |
Genmab | 2,204 |
PCVX News
- 7 weeks ago - Vaxcyte to Present at the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Vaxcyte's Broad-Spectrum Pneumococcal Vaccines Poised For Market Dominance By 2027 - Seeking Alpha
- 2 months ago - Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 months ago - Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy - Seeking Alpha
- 2 months ago - Vaxcyte's stock dips after biotech completes $1.42 billion stock offering - Market Watch
- 2 months ago - Vaxcyte to raise $1.3 bln from shares, warrants sale after stock's surge to record high - Reuters
- 2 months ago - Vaxcyte Announces Pricing of $1.3 Billion Public Offering - GlobeNewsWire
- 2 months ago - Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire